DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Navidea Biopharmaceutical Q4 EPS $(0.15) Misses $(0.12) Estimate, Sales $119.299K Down From $119.321K YoY

Navidea Biopharmaceutical (AMEX:NAVB) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.12) by 25 percent. This is a 650 percent decrease over losses of $(0.02) per share

Benzinga · 03/11/2020 20:06

Navidea Biopharmaceutical (AMEX:NAVB) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.12) by 25 percent. This is a 650 percent decrease over losses of $(0.02) per share from the same period last year. The company reported $119.299 thousand in sales this quarter. This is a 0.02 percent decrease over sales of $119.321 thousand the same period last year.